• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期阿片类药物治疗定义的变化:使用常规收集数据的观察性研究的系统评价(2000-2019 年)。

Variations in Long-term Opioid Therapy Definitions: A Systematic Review of Observational Studies Using Routinely Collected Data (2000-2019).

机构信息

Centre for Big Data Research in Health, Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia.

Brown University Warren Alpert Medical School, Providence, Rhode Island, USA.

出版信息

Br J Clin Pharmacol. 2021 Oct;87(10):3706-3720. doi: 10.1111/bcp.14798. Epub 2021 Mar 16.

DOI:10.1111/bcp.14798
PMID:33629352
Abstract

Routinely collected data have been increasingly used to assess long-term opioid therapy (LTOT) patterns, with very little guidance on how to measure LTOT from these data sources. We conducted a systematic review of studies published between January 2000 and July 2019 to catalogue LTOT definitions, the rationale for definitions and LTOT rates in observational research using routinely collected data in nonsurgical settings. We screened 4056 abstracts, 210 full-text manuscripts and included 128 studies, mostly from the United States (81%) and published between 2015 and 2019 (69%). We identified 78 definitions of LTOT, commonly operationalised as 90 days of use within a year (23%). Studies often used multiple criteria to derive definitions (60%), mostly based on measures of duration, such as supply days/days of use (66%), episode length (21%) or prescription fills within specified time periods (12%). Definitions were based on previous publications (63%), clinical judgment (16%) or empirical data (3%); 10% of studies applied more than one definition. LTOT definition was not provided with enough details for replication in 14 studies and 38 studies did not specify the opioids evaluated. Rates of LTOT within study populations ranged from 0.2% to 57% according to study design and definition used. We observed a substantial rise in the last 5 years in studies evaluating LTOT with large variability in the definitions used and poor reporting of the rationale and implementation of definitions. This variation impacts on research reproducibility, comparability of findings and the development of strategies aiming to curb therapy that is not guideline-recommended.

摘要

常规收集的数据已越来越多地用于评估长期阿片类药物治疗(LTOT)模式,但对于如何从这些数据源中测量 LTOT,几乎没有指导。我们对 2000 年 1 月至 2019 年 7 月期间发表的研究进行了系统回顾,以编目非手术环境中使用常规收集数据的观察性研究中的 LTOT 定义、定义的基本原理和 LTOT 率。我们筛选了 4056 篇摘要、210 篇全文,并纳入了 128 项研究,这些研究主要来自美国(81%)和 2015 年至 2019 年期间发表的研究(69%)。我们确定了 78 种 LTOT 定义,通常将一年内使用 90 天定义为 LTOT(23%)。研究通常使用多种标准来推导定义(60%),主要基于持续时间的测量,例如供应天数/使用天数(66%)、疗程长度(21%)或特定时间段内的处方填充量(12%)。定义基于以前的出版物(63%)、临床判断(16%)或经验数据(3%);10%的研究应用了多种定义。14 项研究没有提供足够的 LTOT 定义细节以供复制,38 项研究没有指定评估的阿片类药物。根据研究设计和使用的定义,研究人群中的 LTOT 率从 0.2%到 57%不等。我们观察到,在过去的 5 年中,评估 LTOT 的研究数量大幅增加,使用的定义差异很大,并且对定义的基本原理和实施情况的报告也很差。这种变化会影响研究的可重复性、研究结果的可比性以及旨在遏制不符合指南推荐的治疗的策略的制定。

相似文献

1
Variations in Long-term Opioid Therapy Definitions: A Systematic Review of Observational Studies Using Routinely Collected Data (2000-2019).长期阿片类药物治疗定义的变化:使用常规收集数据的观察性研究的系统评价(2000-2019 年)。
Br J Clin Pharmacol. 2021 Oct;87(10):3706-3720. doi: 10.1111/bcp.14798. Epub 2021 Mar 16.
2
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
3
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
The measurement and monitoring of surgical adverse events.手术不良事件的测量与监测
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.
6
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.成人癫痫新药的临床疗效、耐受性及成本效益:一项系统评价与经济学评估
Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. doi: 10.3310/hta9150.
7
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
8
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
9
Control interventions in randomised trials among people with mental health disorders.精神障碍患者随机试验中的对照干预措施。
Cochrane Database Syst Rev. 2022 Apr 4;4(4):MR000050. doi: 10.1002/14651858.MR000050.pub2.
10
Interventions for central serous chorioretinopathy: a network meta-analysis.中心性浆液性脉络膜视网膜病变的干预措施:一项网状Meta分析
Cochrane Database Syst Rev. 2025 Jun 16;6(6):CD011841. doi: 10.1002/14651858.CD011841.pub3.

引用本文的文献

1
Predictors of persistent opioid use in Australian primary care: A retrospective cohort study, 2018-2022.澳大利亚初级医疗中持续使用阿片类药物的预测因素:一项2018 - 2022年的回顾性队列研究
Pain Med. 2024 Aug 6;25(12):748-57. doi: 10.1093/pm/pnae071.
2
Varying definitions of long-term opioid therapy: examining prevalence, prescription patterns, and substance-related adverse outcomes.长期阿片类药物治疗的不同定义:审视患病率、处方模式及物质相关不良后果。
Pain Med. 2024 Nov 1;25(11):687-689. doi: 10.1093/pm/pnae051.
3
Impact of prescribed opioid use on development of dementia among patients with chronic non-cancer pain.
处方阿片类药物使用对慢性非癌痛患者痴呆发展的影响。
Sci Rep. 2024 Feb 9;14(1):3313. doi: 10.1038/s41598-024-53728-3.
4
Reductions in sustained prescription opioid use within the US between 2017 and 2021.2017 年至 2021 年期间美国持续处方类阿片使用量减少。
Sci Rep. 2024 Jan 16;14(1):1432. doi: 10.1038/s41598-024-52032-4.
5
Association Between Opioid Dose Reduction Rates and Overdose Among Patients Prescribed Long-Term Opioid Therapy.长期阿片类药物治疗患者的阿片类药物剂量减少率与过量之间的关联。
Subst Abus. 2023 Jul;44(3):209-219. doi: 10.1177/08897077231186216. Epub 2023 Sep 13.
6
Five-Year Trajectories of Prescription Opioid Use.五年内处方类阿片类药物使用情况的变化轨迹
JAMA Netw Open. 2023 Aug 1;6(8):e2328159. doi: 10.1001/jamanetworkopen.2023.28159.
7
COVID-19 restrictions and the incidence and prevalence of prescription opioid use in Australia - a nationwide study.澳大利亚的 COVID-19 限制措施与处方类阿片使用的发病率和流行率:一项全国性研究。
Br J Clin Pharmacol. 2023 Feb;89(2):914-920. doi: 10.1111/bcp.15577. Epub 2022 Nov 25.